2,071 research outputs found
Sexual dimorphism, female fertility, and diet of Physalaemus feioi (Anura: Leptodactylidae) from southeastern Brazil
Physalaemus feioi é uma rã da América do Sul, endêmica da Mata Atlântica, registrada nos estados de Minas Gerais e São Paulo. Avaliamos o dimorfismo sexual, a fertilidade nas fêmeas e dieta dessa espécie em duas localidades do estado de Minas Gerais, incluindo a localidade-tipo da espécie. Coletamos 73 indivíduos (16 fêmeas adultas e 57 machos adultos) por meio de busca ativa. O número de oócitos encontrados para P. feioi (x̅ = 1385 ± 498,13) foi alto quando comparado com outras espécies do gênero como P. maculiventris, P. signifer, P. cuvieri e P. ephippifer mas este semelha o número de oócitos de P. centralis, P. kroyeri e P. marmoratus. As presas com maior índice de importância foram Coleoptera (IIR = 24,26) e Formicidae (IIR = 16,46). Não houve diferenças entre machos e fêmeas quanto ao número de presas ingeridas e nem o volume do conteúdo estomacal. Em resumo, Physalaemus feioi teve semelhanças com outras espécies do gênero em relação ao dimorfismo sexual, fecundidade e hábitos alimentares.Physalaemus feioi is a South American frog endemic to the Brazilian Atlantic Forest that occurs in the states of Minas Gerais and São Paulo. We evaluated sexual dimorphism, female fertility, and diet of P. feioi from two locations in the state of Minas Gerais, including the type locality of the species. We collected 73 individuals (16 adult females and 57 adult males). The number of oocytes of P. feioi (x̅ = 1385 ±498.13) was higher than in other species of the genus, such as P. maculiventris, P. signifer, P. cuvieri, and P. ephippifer, but it resembles that of P. centralis, P. kroyeri, and P. marmoratus. The prey items with the highest index of importance were Coleoptera (IIR = 24.26) and Formicidae (IIR = 16.46). We found no sex differences regarding the number of ingested prey and the volume of the stomach contents. In summary, Physalaemus feioi was similar to other species of the genus regarding sexual dimorphism, fecundity, and feeding habits
Diet of Dermatonotus muelleri (Anura: Microhylidae) in a semideciduous forest in western Brazil
Anurans are important predators and preys in neotropical food webs linking different trophic levels. A small portion of them are specialist predator what is related with mouth size and morphology. Herein, we report the diet of Dermatonotus muelleri (Microhylidae) from a semideciduous forest in Western Brazil. We collected a total of 63 adults of D. muelleri (females and males) from the Selvíria municipality, Mato Grosso do Sul State, Brazil. We did not find differences between male and female diet composition. The most frequent preys found were isopterans (63.34%) and hymenopterans (26.67%). All hymenopterans identified belong to the Formicidae family. Our results defined Dermatonotus muelleri as an ant-specialist predator and agree with previous studies about the diets of neotropical Microhylid frogs like Chiasmocleis albopunctata, C. bassleri, C. capixaba, C. hudsoni, C. jimi, C. leucosticta, C. shudikarensis, C.ventrimaculata, Ctenophryne geayi, Elachistocleis bicolor, E. ovalis, E. pearsei, and E. panamensis.Asociación Herpetológica Argentin
Diet of Dermatonotus muelleri (Anura: Microhylidae) in a semideciduous forest in western Brazil
Anurans are important predators and preys in neotropical food webs linking different trophic levels. A small portion of them are specialist predator what is related with mouth size and morphology. Herein, we report the diet of Dermatonotus muelleri (Microhylidae) from a semideciduous forest in Western Brazil. We collected a total of 63 adults of D. muelleri (females and males) from the Selvíria municipality, Mato Grosso do Sul State, Brazil. We did not find differences between male and female diet composition. The most frequent preys found were isopterans (63.34%) and hymenopterans (26.67%). All hymenopterans identified belong to the Formicidae family. Our results defined Dermatonotus muelleri as an ant-specialist predator and agree with previous studies about the diets of neotropical Microhylid frogs like Chiasmocleis albopunctata, C. bassleri, C. capixaba, C. hudsoni, C. jimi, C. leucosticta, C. shudikarensis, C.ventrimaculata, Ctenophryne geayi, Elachistocleis bicolor, E. ovalis, E. pearsei, and E. panamensis.Asociación Herpetológica Argentin
A Giant Planet Candidate Transiting a White Dwarf
Astronomers have discovered thousands of planets outside the solar system,
most of which orbit stars that will eventually evolve into red giants and then
into white dwarfs. During the red giant phase, any close-orbiting planets will
be engulfed by the star, but more distant planets can survive this phase and
remain in orbit around the white dwarf. Some white dwarfs show evidence for
rocky material floating in their atmospheres, in warm debris disks, or orbiting
very closely, which has been interpreted as the debris of rocky planets that
were scattered inward and tidally disrupted. Recently, the discovery of a
gaseous debris disk with a composition similar to ice giant planets
demonstrated that massive planets might also find their way into tight orbits
around white dwarfs, but it is unclear whether the planets can survive the
journey. So far, the detection of intact planets in close orbits around white
dwarfs has remained elusive. Here, we report the discovery of a giant planet
candidate transiting the white dwarf WD 1856+534 (TIC 267574918) every 1.4
days. The planet candidate is roughly the same size as Jupiter and is no more
than 14 times as massive (with 95% confidence). Other cases of white dwarfs
with close brown dwarf or stellar companions are explained as the consequence
of common-envelope evolution, wherein the original orbit is enveloped during
the red-giant phase and shrinks due to friction. In this case, though, the low
mass and relatively long orbital period of the planet candidate make
common-envelope evolution less likely. Instead, the WD 1856+534 system seems to
demonstrate that giant planets can be scattered into tight orbits without being
tidally disrupted, and motivates searches for smaller transiting planets around
white dwarfs.Comment: 50 pages, 12 figures, 2 tables. Published in Nature on Sept. 17,
2020. The final authenticated version is available online at:
https://www.nature.com/articles/s41586-020-2713-
Too Big to Fail — U.S. Banks’ Regulatory Alchemy: Converting an Obscure Agency Footnote into an “At Will” Nullification of Dodd-Frank’s Regulation of the Multi-Trillion Dollar Financial Swaps Market
The multi-trillion-dollar market for, what was at that time wholly unregulated, over-the-counter derivatives (“swaps”) is widely viewed as a principal cause of the 2008 worldwide financial meltdown. The Dodd-Frank Act, signed into law on July 21, 2010, was expressly considered by Congress to be a remedy for this troublesome deregulatory problem. The legislation required the swaps market to comply with a host of business conduct and anti-competitive protections, including that the swaps market be fully transparent to U.S. financial regulators, collateralized, and capitalized. The statute also expressly provides that it would cover foreign subsidiaries of big U.S. financial institutions if their swaps trading could adversely impact the U.S. economy or represent the use of extraterritorial trades as an attempt to “evade” Dodd-Frank. In July 2013, the CFTC promulgated an 80-page, triple-columned, and single-spaced “guidance” implementing Dodd-Frank’s extraterritorial reach, i.e., that manner in which Dodd-Frank would apply to swaps transactions executed outside the United States. The key point of that guidance was that swaps trading within the “guaranteed” foreign subsidiaries of U.S. bank holding company swaps dealers were subject to all of Dodd-Frank’s swaps regulations wherever in the world those subsidiaries’ swaps were executed. At that time, the standardized industry swaps agreement contemplated that, inter alia, U.S. bank holding company swaps dealers’ foreign subsidiaries would be “guaranteed” by their corporate parent, as was true since 1992. In August 2013, without notifying the CFTC, the principal U.S. bank holding company swaps dealer trade association privately circulated to its members standard contractual language that would, for the first time, “deguarantee” their foreign subsidiaries. By relying only on the obscure footnote 563 of the CFTC guidance’s 662 footnotes, the trade association assured its swaps dealer members that the newly deguaranteed foreign subsidiaries could (if they so chose) no longer be subject to Dodd-Frank. As a result, it has been reported (and it also has been understood by many experts within the swaps industry) that a substantial portion of the U.S. swaps market has shifted from the large U.S. bank holding companies swaps dealers and their U.S. affiliates to their newly deguaranteed “foreign” subsidiaries, with the attendant claim by these huge big U.S. bank swaps dealers that Dodd-Frank swaps regulation would not apply to these transactions. The CFTC also soon discovered that these huge U.S. bank holding company swaps dealers were “arranging, negotiating, and executing” (“ANE”) these swaps in the United States with U.S. bank personnel and, only after execution in the U.S., were these swaps formally “assigned” to the U.S. banks’ newly “deguaranteed” foreign subsidiaries with the accompanying claim that these swaps, even though executed in the U.S., were not covered by Dodd-Frank. In October 2016, the CFTC proposed a rule that would have closed the “deguarantee” and “ANE” loopholes completely. However, because it usually takes at least a year to finalize a “proposed” rule, this proposed rule closing the loopholes in question was not finalized prior to the inauguration of President Trump. All indications are that it will never be finalized during a Trump Administration. Thus, in the shadow of the recent tenth anniversary of the Lehman failure, there is an understanding among many market regulators and swaps trading experts that large portions of the swaps market have moved from U.S. bank holding company swaps dealers and their U.S. affiliates to their newly deguaranteed foreign affiliates where Dodd- Frank swaps regulation is not being followed. However, what has not moved abroad is the very real obligation of the lender of last resort to rescue these U.S. swaps dealer bank holding companies if they fail because of poorly regulated swaps in their deguaranteed foreign subsidiaries, i.e., the U.S. taxpayer. While relief is unlikely to be forthcoming from the Trump Administration or the Republican-controlled Senate, some other means will have to be found to avert another multi-trillion-dollar bank bailout and/or a financial calamity caused by poorly regulated swaps on the books of big U.S. banks. This paper notes that the relevant statutory framework affords state attorneys general and state financial regulators the right to bring so-called “parens patriae” actions in federal district court to enforce, inter alia, Dodd- Frank on behalf of a state’s citizens. That kind of litigation to enforce the statute’s extraterritorial provisions is now badly needed
Recommended from our members
An inhibitor of oxidative phosphorylation exploits cancer vulnerability.
Metabolic reprograming is an emerging hallmark of tumor biology and an actively pursued opportunity in discovery of oncology drugs. Extensive efforts have focused on therapeutic targeting of glycolysis, whereas drugging mitochondrial oxidative phosphorylation (OXPHOS) has remained largely unexplored, partly owing to an incomplete understanding of tumor contexts in which OXPHOS is essential. Here, we report the discovery of IACS-010759, a clinical-grade small-molecule inhibitor of complex I of the mitochondrial electron transport chain. Treatment with IACS-010759 robustly inhibited proliferation and induced apoptosis in models of brain cancer and acute myeloid leukemia (AML) reliant on OXPHOS, likely owing to a combination of energy depletion and reduced aspartate production that leads to impaired nucleotide biosynthesis. In models of brain cancer and AML, tumor growth was potently inhibited in vivo following IACS-010759 treatment at well-tolerated doses. IACS-010759 is currently being evaluated in phase 1 clinical trials in relapsed/refractory AML and solid tumors
Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA)
The International Agency for Research on Cancer (IARC) Monographs Programme identifies chemicals, drugs, mixtures, occupational exposures, lifestyles and personal habits, and physical and biological agents that cause cancer in humans and has evaluated about 1000 agents since 1971. Monographs are written by ad hoc Working Groups (WGs) of international scientific experts over a period of about 12 months ending in an eight-day meeting. The WG evaluates all of the publicly available scientific information on each substance and, through a transparent and rigorous process,1 decides on the degree to which the scientific evidence supports that substance's potential to cause or not cause cancer in humans. For Monograph 112,2 17 expert scientists evaluated the carcinogenic hazard for four insecticides and the herbicide glyphosate.3 The WG concluded that the data for glyphosate meet the criteria for classification as a probable human carcinogen. The European Food Safety Authority (EFSA) is the primary agency of the European Union for risk assessments regarding food safety. In October 2015, EFSA reported4 on their evaluation of the Renewal Assessment Report5 (RAR) for glyphosate that was prepared by the Rapporteur Member State, the German Federal Institute for Risk Assessment (BfR). EFSA concluded that ?glyphosate is unlikely to pose a carcinogenic hazard to humans and the evidence does not support classification with regard to its carcinogenic potential?. Addendum 1 (the BfR Addendum) of the RAR5 discusses the scientific rationale for differing from the IARC WG conclusion. Serious flaws in the scientific evaluation in the RAR incorrectly characterise the potential for a carcinogenic hazard from exposure to glyphosate. Since the RAR is the basis for the European Food Safety Agency (EFSA) conclusion,4 it is critical that these shortcomings are corrected
Madagascar’s extraordinary biodiversity: Threats and opportunities
Madagascar's unique biota is heavily affected by human activity and is under intense threat. Here, we review the current state of knowledge on the conservation status of Madagascar's terrestrial and freshwater biodiversity by presenting data and analyses on documented and predicted species-level conservation statuses, the most prevalent and relevant threats, ex situ collections and programs, and the coverage and comprehensiveness of protected areas. The existing terrestrial protected area network in Madagascar covers 10.4% of its land area and includes at least part of the range of the majority of described native species of vertebrates with known distributions (97.1% of freshwater fishes, amphibians, reptiles, birds, and mammals combined) and plants (67.7%). The overall figures are higher for threatened species (97.7% of threatened vertebrates and 79.6% of threatened plants occurring within at least one protected area). International Union for Conservation of Nature (IUCN) Red List assessments and Bayesian neural network analyses for plants identify overexploitation of biological resources and unsustainable agriculture as themost prominent threats to biodiversity. We highlight five opportunities for action at multiple levels to ensure that conservation and ecological restoration objectives, programs, and activities take account of complex underlying and interacting factors and produce tangible benefits for the biodiversity and people of Madagascar
Madagascar’s extraordinary biodiversity: Evolution, distribution, and use
Madagascar's biota is hyperdiverse and includes exceptional levels of endemicity. We review the current state of knowledge on Madagascar's past and current terrestrial and freshwater biodiversity by compiling and presenting comprehensive data on species diversity, endemism, and rates of species description and human uses, in addition to presenting an updated and simplified map of vegetation types. We report a substantial increase of records and species new to science in recent years; however, the diversity and evolution of many groups remain practically unknown (e.g., fungi and most invertebrates). Digitization efforts are increasing the resolution of species richness patterns and we highlight the crucial role of field- and collections-based research for advancing biodiversity knowledge and identifying gaps in our understanding, particularly as species richness corresponds closely to collection effort. Phylogenetic diversity patterns mirror that of species richness and endemism in most of the analyzed groups. We highlight humid forests as centers of diversity and endemism because of their role as refugia and centers of recent and rapid radiations. However, the distinct endemism of other areas, such as the grassland-woodland mosaic of the Central Highlands and the spiny forest of the southwest, is also biologically important despite lower species richness. The documented uses of Malagasy biodiversity are manifold, with much potential for the uncovering of new useful traits for food, medicine, and climate mitigation. The data presented here showcase Madagascar as a unique living laboratory for our understanding of evolution and the complex interactions between people and nature. The gathering and analysis of biodiversity data must continue and accelerate if we are to fully understand and safeguard this unique subset of Earth's biodiversity
Diabetes-Specific Nutrition Algorithm: A Transcultural Program to Optimize Diabetes and Prediabetes Care
Type 2 diabetes (T2D) and prediabetes have a major global impact through high disease prevalence, significant downstream pathophysiologic effects, and enormous financial liabilities. To mitigate this disease burden, interventions of proven effectiveness must be used. Evidence shows that nutrition therapy improves glycemic control and reduces the risks of diabetes and its complications. Accordingly, diabetes-specific nutrition therapy should be incorporated into comprehensive patient management programs. Evidence-based recommendations for healthy lifestyles that include healthy eating can be found in clinical practice guidelines (CPGs) from professional medical organizations. To enable broad implementation of these guidelines, recommendations must be reconstructed to account for cultural differences in lifestyle, food availability, and genetic factors. To begin, published CPGs and relevant medical literature were reviewed and evidence ratings applied according to established protocols for guidelines. From this information, an algorithm for the nutritional management of people with T2D and prediabetes was created. Subsequently, algorithm nodes were populated with transcultural attributes to guide decisions. The resultant transcultural diabetes-specific nutrition algorithm (tDNA) was simplified and optimized for global implementation and validation according to current standards for CPG development and cultural adaptation. Thus, the tDNA is a tool to facilitate the delivery of nutrition therapy to patients with T2D and prediabetes in a variety of cultures and geographic locations. It is anticipated that this novel approach can reduce the burden of diabetes, improve quality of life, and save lives. The specific Southeast Asian and Asian Indian tDNA versions can be found in companion articles in this issue of Current Diabetes Reports
- …